Search for a report

GLOBAL DRUG DISCOVERY MARKET FORECAST 2022-2030

  • You are here:
  • Home
  • Downloads
  • GLOBAL DRUG DISCOVERY MARKET FORECAST 2022-2030

GLOBAL DRUG DISCOVERY MARKET FORECAST 2022-2030

The global drug discovery market is expected to reach $101.66 billion by 2030, growing at a CAGR of 6.58% during the forecast period, 2022-2030. The base year considered for the study is 2021, and the estimated period is between 2022 and 2030.

GLOBAL DRUG DISCOVERY MARKET FORECAST 2022-2030

Global Drug Discovery Market by Drug Type (Small Molecule Drug, Biologic Drug) Market by Service (Chemical Services, Drug Metabolism and Pharmacokinetics Services, Biological Services, Other Pharmaceutical Services) Market by End-users (Pharmaceutical Companies, Contract Research Organizations, Research Institutes, Other End-users) Market by Technology (High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics and Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies) by Geography

Request free sample

The global drug discovery market is expected to reach $101.66 billion by 2030, growing at a CAGR of 6.58% during the forecast period, 2022-2030. The base year considered for the study is 2021, and the estimated period is between 2022 and 2030. The market study has also analyzed the impact of COVID-19 on the drug discovery industry qualitatively as well as quantitatively.

To learn more about this report, request a free sample copy

The importance of the drug discovery and development market is not limited to capital opportunities that companies can gain post developing successful drugs, but it is also vital as it can help fight and overcome various diseases and health conditions present globally. It gained more relevance and traction during the COVID-19 pandemic.

Governments, companies, and research organizations globally emphasize the importance of developing novel and effective drugs to fight mainstream and rare diseases.

Drug Discovery Market

Read our latest blog on the Drug Discovery Market

Key enablers of the global drug discovery market growth are:

  • Growing R&D for tackling several diseases
    • Major pharmaceutical companies are increasing their focus on health conditions/diseases like cardiology, oncology, women’s health, infectious diseases, etc. These areas are related to the rising cases of diseases or conditions such as cardiac arrest, different cancer types, and recent risks such as COVID-19. Companies anticipate the growth in the number of incidences, and accordingly plan their resources and research in related drug discovery and development processes.
    • Many big players have multiple development projects in the pipeline on such diseases. The successful outcomes of projects will help companies seize the opportunity and earn profits. Such increased R&D efforts by companies, CROs, and research institutes will drive the overall drug discovery and development market growth.
  • Technological advancements

Key growth restraining factors are:

  • Time-consuming process
  • Highly regulated market
  • Project feasibility and success rate
    • The drug discovery and development process are time-consuming, but the success of the projects in the pipeline is not guaranteed. A pharma company or CRO may spend millions of dollars or use advanced technologies available and still fail to derive projected or desired outcomes. This factor hinders the overall market growth.
    • A project can fail at any given phase or clinical trial. It may also be discontinued due to safety issues of the drug found, or the company may fail to follow standards prescribed by the regulatory authority and thus may not get authorization for production and commercialization of the drug.
    • For example, AstraZeneca had to discontinue the AZD2048 project for respiratory health in Phase 1 due to safety and efficacy reasons. Also, it terminated the ALXN1830 project under development for Warm Autoimmune Hemolytic Anaemia, in Phase 1 due to strategic reasons.

Drug Discovery Market | Top Trends

  • Research and development are an integral part of pharmaceutical companies. Due to fierce competition, rising diseases, poor health conditions, etc., companies have to be innovative to sustain the market rivalry. Other than sales and marketing of existing drugs, it is equally important for companies to keep finding new drugs that can be more effective than existing solutions.
  • Drug discovery & development is a highly scientific and complex process for which technical aid is needed to execute the process successfully. Current technologies in use are high throughput screening, spectroscopy, combinatorial chemistry, biochips, pharmacogenomics and pharmacogenetics, bioinformatics, metabolomics, nanotechnology, etc. These technologies are crucial in the drug development process, and are used by pharmaceutical companies, contract research organizations, and other research institutes.
  • From past experiences, market players have observed and understood the importance of industry collaborations and partnerships to grow. Collaborations help players exchange knowledge, transfer technology, share expertise, etc. This factor is very important in the drug discovery and development market because hardly any player or company can have first-hand knowledge, proficiency, or capability to carry out complex processes such as drug discovery.

Market Segmentation Analysis – Drug Type, Service, End-User, and Technology –

Market by Drug Type:

  • Small Molecule Drug
  • Biologic Drug

Market by Service:

  • Chemical Services
  • Drug Metabolism and Pharmacokinetics Services
  • Biological Services
  • Other Pharmaceutical Services

Market by End-User:

  • Pharmaceutical Companies
    • In 2021, the majority of the market share was captured by the pharmaceutical companies segment in the market by end-user.
    • Pharmaceutical companies play a major role in drug discovery areas. They have mainly two focus areas, research & development of drugs and marketing & sale of drugs.
    • Big pharmaceutical players like Pfizer, Merck and Co Inc, GlaxoSmithKline Plc, etc., have their in-house research facilities for drug discovery and development.
    • The drug discovery process is lengthy, and thus market players undertake collaborative efforts or fund projects of other research institutes to obtain the formulation and drug.
  • Contract Research Organizations
  • Research Institutes
  • Other End-Users

Market by Technology:

  • High Throughput Screening
  • Spectroscopy
  • Combinatorial Chemistry
  • Biochips
  • Pharmacogenomics and Pharmacogenetics
  • Bioinformatics
    • Bioinformatics is anticipated to be the fastest-growing technology, projecting a CAGR of 8.33%.
    • Bioinformatics is a discipline that comprises biology and computer science that deals with the acquisition, storage, analysis, and dissemination of biological data, most often DNA and amino acid sequences.
    • Bioinformatics uses computer programs for various applications. These include three-dimensional shapes of proteins prediction, establishing evolutionary relationships, and gene and protein function determination.
  • Metabolomics
  • Nanotechnology
  • Other Technologies

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
  • Europe: United Kingdom, Germany, France, Italy, Russia, Spain, Scandinavia, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Indonesia, Singapore, Taiwan, Australia & New Zealand, and Rest of Asia-Pacific
    • The Asia-Pacific drug discovery market is anticipated to be the fastest-growing market.
    • Asian countries are preferred for their cost-saving abilities and large-scale manufacturing capacities. Also, companies are extending their presence in order to leverage these factors.
    • With accessibility to a large population and ever-increasing pressure on the healthcare sector, Asia-Pacific provides ample opportunities to research and conduct clinical trials for CROs and pharmaceuticals.
  • Rest of World: Latin America, Middle East & Africa

The major players in the global drug discovery market are:

  • Pfizer Inc
  • GlaxoSmithKline PLC
  • Charles River Laboratories International
  • Evotec SE
  • AstraZeneca PLC
  • Icon PLC

Key strategies adopted by some of these companies:

  • Agilent Technologies Inc bought Virtual Control, an AI and machine learning software company, in February 2022 with the goal of obtaining innovative lab testing analytical solutions built by them. Agilent will use the software in its mass spectrometry (GS/MS) and gas chromatography platforms for improving efficiency, productivity, and accuracy.
  • Bayer launched a Phase II, three-arm study in February 2022 to compare finerenone plus the SGLT2 inhibitor empagliflozin in individuals with chronic kidney disease (CKD) and Type 2 diabetes against finerenone alone and empagliflozin alone (T2D).
  • Roche and Shape Tx signed a research collaboration and licensed agreement in August 2021 to develop medicines for specific targets in Alzheimer’s disease, Parkinson’s disease, and uncommon disorders.

 

Report Synopsis:

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Drug Type, Service, End-User, and Technology
Geographies Analyzed North America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed

Roche AG, Pfizer Inc, Bayer AG, Evotec SE, Agilent Technologies Inc, Icon Plc, AstraZeneca Plc, Charles River Laboratories International Inc, Novartis AG, Merck & Co Inc, Eli Lilly and Company, IQVIA Holdings Inc, Johnson & Johnson, and GlaxoSmithKline Plc

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • GROWING R&D FOR TACKLING SEVERAL DISEASES
      • TECHNOLOGICAL ADVANCEMENTS
    • KEY RESTRAINTS
      • EXTENSIVE TIME-CONSUMING PROCESS
      • HIGHLY REGULATED MARKET
      • PROJECT FEASIBILITY AND SUCCESS RATE
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON GLOBAL DRUG DISCOVERY MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • DRUG DISCOVERY AND DEVELOPMENT PROCESS
      • DRUG DISCOVERY AND DEVELOPMENT
      • PRECLINICAL RESEARCH
      • CLINICAL RESEARCH
      • REGULATORY AUTHORITY REVIEW
      • POST MARKET SAFETY MONITORING
    • REGULATORY FRAMEWORK
  2. MARKET BY DRUG TYPE
    • SMALL MOLECULE DRUG
    • BIOLOGIC DRUG
  3. MARKET BY SERVICE
    • CHEMICAL SERVICES
    • DRUG METABOLISM AND PHARMACOKINETICS SERVICES
    • BIOLOGICAL SERVICES
    • OTHER PHARMACEUTICAL SERVICES
  4. MARKET BY END-USERS
    • PHARMACEUTICAL COMPANIES
    • CONTRACT RESEARCH ORGANIZATIONS
    • RESEARCH INSTITUTES
    • OTHER END-USERS
  5. MARKET BY TECHNOLOGY
    • HIGH THROUGHPUT SCREENING
    • SPECTROSCOPY
    • COMBINATORIAL CHEMISTRY
    • BIOCHIPS
    • PHARMACOGENOMICS AND PHARMACOGENETICS
    • BIOINFORMATICS
    • METABOLOMICS
    • NANOTECHNOLOGY
    • OTHER TECHNOLOGIES
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • SPAIN
        • SCANDINAVIA
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • SINGAPORE
        • TAIWAN
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS & DIVESTITURES
    • COMPANY PROFILES
      • AGILENT TECHNOLOGIES INC
      • ASTRAZENECA PLC
      • BAYER AG
      • CHARLES RIVER LABORATORIES INTERNATIONAL INC
      • ELI LILLY AND COMPANY
      • EVOTEC SE
      • GLAXOSMITHKLINE PLC
      • ICON PLC
      • IQVIA HOLDINGS INC
      • JOHNSON & JOHNSON
      • MERCK & CO INC
      • NOVARTIS AG
      • PFIZER INC
      • ROCHE AG

LIST OF TABLES  

TABLE 1:  MARKET SNAPSHOT – GLOBAL DRUG DISCOVERY

TABLE 2:  REGULATORY FRAMEWORK

TABLE 3:  GLOBAL DRUG DISCOVERY MARKET, BY DRUG TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 4:  GLOBAL DRUG DISCOVERY MARKET, BY DRUG TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 5:  GLOBAL SMALL MOLECULE DRUG MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6:  GLOBAL SMALL MOLECULE DRUG MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7:  GLOBAL BIOLOGIC DRUG MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8:  GLOBAL BIOLOGIC DRUG MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9:  GLOBAL DRUG DISCOVERY MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10:  GLOBAL DRUG DISCOVERY MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11:  GLOBAL CHEMICAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12:  GLOBAL CHEMICAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13:  GLOBAL DRUG METABOLISM AND PHARMACOKINETICS SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14:  GLOBAL DRUG METABOLISM AND PHARMACOKINETICS SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15:  GLOBAL BIOLOGICAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16:  GLOBAL BIOLOGICAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17:  GLOBAL OTHER PHARMACEUTICAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18:  GLOBAL OTHER PHARMACEUTICAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19:  GLOBAL DRUG DISCOVERY MARKET, BY END-USERS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 20:  GLOBAL DRUG DISCOVERY MARKET, BY END-USERS, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 21:  GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 22:  GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 23:  GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 24:  GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 25:  GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 26:  GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 27:  GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 28:  GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 29:  GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 30:  GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 31:  GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 32:  GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 33:  GLOBAL SPECTROSCOPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 34:  GLOBAL SPECTROSCOPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 35:  GLOBAL COMBINATORIAL CHEMISTRY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 36:  GLOBAL COMBINATORIAL CHEMISTRY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 37:  GLOBAL BIOCHIPS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 38:  GLOBAL BIOCHIPS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 39:  GLOBAL PHARMACOGENOMICS AND PHARMACOGENETICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 40:  GLOBAL PHARMACOGENOMICS AND PHARMACOGENETICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 41:  GLOBAL BIOINFORMATICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 42:  GLOBAL BIOINFORMATICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 43:  GLOBAL METABOLOMICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 44:  GLOBAL METABOLOMICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 45:  GLOBAL NANOTECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 46:  GLOBAL NANOTECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 47:  GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 48:  GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 49:  GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 50:  GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 51:  NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 52:  NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 53:  LEADING PLAYERS OPERATING IN NORTH AMERICA DRUG DISCOVERY MARKET

TABLE 54:  EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 55:  EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 56:  LEADING PLAYERS OPERATING IN EUROPE DRUG DISCOVERY MARKET

TABLE 57:  ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 58:  ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 59:  LEADING PLAYERS OPERATING IN ASIA-PACIFIC DRUG DISCOVERY MARKET

TABLE 60:  REST OF WORLD DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 61:  REST OF WORLD DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 62:  LEADING PLAYERS OPERATING IN REST OF WORLD DRUG DISCOVERY MARKET

TABLE 63:  LIST OF MERGERS & ACQUISITIONS

TABLE 64:  LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 65:  LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 66:  LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: DRUG DISCOVERY AND DEVELOPMENT PROCESS

FIGURE 5: GLOBAL DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY DRUG TYPE, IN 2021

FIGURE 6: GLOBAL DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2022-2030 (IN $ MILLION)

FIGURE 7: GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2022-2030 (IN $ MILLION)

FIGURE 8: GLOBAL DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021

FIGURE 9: GLOBAL DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS SERVICES, 2022-2030 (IN $ MILLION)

FIGURE 11: GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY END-USERS, IN 2021

FIGURE 14: GLOBAL DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)

FIGURE 15: GLOBAL DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2022-2030 (IN $ MILLION)

FIGURE 17: GLOBAL DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)

FIGURE 18: GLOBAL DRUG DISCOVERY MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

FIGURE 19: GLOBAL DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2022-2030 (IN $ MILLION)

FIGURE 20: GLOBAL DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2022-2030 (IN $ MILLION)

FIGURE 21: GLOBAL DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2022-2030 (IN $ MILLION)

FIGURE 22: GLOBAL DRUG DISCOVERY MARKET, BY BIOCHIPS, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2022-2030 (IN $ MILLION)

FIGURE 24: GLOBAL DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2022-2030 (IN $ MILLION)

FIGURE 25: GLOBAL DRUG DISCOVERY MARKET, BY METABOLOMICS, 2022-2030 (IN $ MILLION)

FIGURE 26: GLOBAL DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2022-2030 (IN $ MILLION)

FIGURE 27: GLOBAL DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2022-2030 (IN $ MILLION)

FIGURE 28: NORTH AMERICA DRUG DISCOVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 29: UNITED STATES DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 30: CANADA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 31: EUROPE DRUG DISCOVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 32: UNITED KINGDOM DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 33: GERMANY DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 34: FRANCE DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 35: ITALY DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 36: RUSSIA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 37: SPAIN DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 38: SCANDINAVIA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 39: REST OF EUROPE DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 40: ASIA-PACIFIC DRUG DISCOVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 41: CHINA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: JAPAN DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: INDIA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 44: SOUTH KOREA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: INDONESIA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 46: SINGAPORE DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 47: TAIWAN DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 48: AUSTRALIA & NEW ZEALAND DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 49: REST OF ASIA-PACIFIC DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 50: REST OF WORLD DRUG DISCOVERY MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 51: LATIN AMERICA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

FIGURE 52: MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET, 2022-2030 (IN $ MILLION)

  1. MARKET BY DRUG TYPE
    • SMALL MOLECULE DRUG
    • BIOLOGIC DRUG
  2. MARKET BY SERVICE
    • CHEMICAL SERVICES
    • DRUG METABOLISM AND PHARMACOKINETICS SERVICES
    • BIOLOGICAL SERVICES
    • OTHER PHARMACEUTICAL SERVICES
  3. MARKET BY END-USERS
    • PHARMACEUTICAL COMPANIES
    • CONTRACT RESEARCH ORGANIZATIONS
    • RESEARCH INSTITUTES
    • OTHER END-USERS
  4. MARKET BY TECHNOLOGY
    • HIGH THROUGHPUT SCREENING
    • SPECTROSCOPY
    • COMBINATORIAL CHEMISTRY
    • BIOCHIPS
    • PHARMACOGENOMICS AND PHARMACOGENETICS
    • BIOINFORMATICS
    • METABOLOMICS
    • NANOTECHNOLOGY
    • OTHER TECHNOLOGIES
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • SPAIN
        • SCANDINAVIA
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • SINGAPORE
        • TAIWAN
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Frequently Asked Questions & Answers (FAQs):

    What is the market size of the global drug discovery market?

    As of 2021, the global drug discovery market was valued at $57.34 billion.

    Does this report include the COVID-19 impact?

    Yes, the market study has also analyzed the impact of COVID-19 on the drug discovery market qualitatively as well as quantitatively.

    Which is the largest revenue-generating region in the global drug discovery market?

    North America is the largest revenue-generating region in the global drug discovery market.

    Which is the fastest-growing end-user in the global drug discovery market?

    Contract Research Organizations (CROs) are the fastest-growing end-user in the global drug discovery market.

    To request a free sample copy of this report, please complete the form below:

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now